Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the ...
The newly formed firm and group are announcing their intention to raise initial bridge financing through offerings under the U.S. SEC's Regulation D and a Hong Kong Stock Exchange (HKEx) debt ...
Nebius Group (NBIS) said it has closed a private offering of convertible senior notes, raising around $4.3B in gross proceeds as the company looks to fund data center build-outs and expand its ...
13d
Ormat Technologies, Inc. Announces Closing of Upsized $1 Billion Convertible Senior Notes Offering
RENO, Nev., March 23, 2026 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (“Company” or “Ormat”) today announced the closing of its previously announced private offering of $1 billion ...
(NYSE: WT) ("WisdomTree"), a global financial innovator, today announced its intention to offer, subject to market conditions ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- indie Semiconductor, Inc. (INDI), an automotive solutions innovator, today announced that it plans to offer, subject to market and other conditions, $150.0 ...
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- WhiteFiber, Inc. (Nasdaq: WYFI) ("WhiteFiber" or the "Company"), a provider purpose-built for artificial intelligence ("AI ...
“We are extremely pleased with the outstanding response to the Convertible Note Offering from high quality institutional investors in the United States, which is a tremendous endorsement of Caledonia ...
Zenas BioPharma, Inc. ('Zenas,” 'Zenas BioPharma” or the 'Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical ...
Hosted on MSN
Compass prices $850M convertible notes offering
Compass (COMP) said it priced an $850 million private offering of convertible senior notes due 2031, up $100 million from the previously announced size. The company also gave initial buyers the option ...
Jefferies, Evercore ISI, Citigroup and Guggenheim Securities are acting as joint-book running managers for the Convertible Notes Offering and Equity Offering. Wedbush PacGrow is acting as co-manager ...
Shares of Zenas BioPharma fell after the clinical-stage biopharmaceutical company said it commenced an underwritten public offering of notes and stock. The stock slipped 9.8%, to $20, after-hours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results